Exponent (EXPO) Q2 2026 Earnings Call Transcript
Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.
How this was made
The 30-second read
Why it matters
The key tradable items are the guidance increases for revenue growth and EBITDA margin, plus capital allocation updates (buyback authorization increase) and operational improvements (utilization, billable hours, technical headcount).
Market read
Guidance upgrades and margin outlook changes are likely to drive earnings estimate revisions and near-term positioning in EXPO.
What to watch
A single large study contributed 4% of revenues and management expects it to moderate; traders may discount the durability of that concentration when modeling forward quarters.
Background
This is Exponent’s Q2 2026 earnings call transcript with detailed financial results, operational KPIs, and updated FY 2026 and Q3 2026 guidance.
Ticker impact
Exponent reported Q2 2026 net revenues of $148.9M (+12%) and raised FY 2026 revenue growth guidance to 9% to 10%.
Likely positive near-term bias as guidance upgrades can re-rate expectations, though buyback-driven interest income drag may temper non-operating optics.
The article discloses multiple forward-looking guidance changes (FY 2026 revenue and EBITDA margin, Q3 revenue and EBITDA margin) and operational KPIs (utilization, billable hours) that typically drive earnings revisions and sentiment.
Market effects
Signals demand strength for AI-enabled user research and failure analysis services, potentially supportive for peers serving similar engineering and human-factors workflows.
No specific regional demand or macro linkage disclosed beyond general client infrastructure timelines.
No direct international expansion or cross-border contract details provided.
Counterpoint
Guidance raises may be partially offset by higher G&A and lower interest income from repurchases, which could pressure net income quality if cash balances keep declining.
Key entities
- companyExponent, Inc.
Reported Q2 2026 results and raised FY 2026 and Q3 2026 guidance; discussed AI-driven user research demand and buyback activity.
- executiveCatherine Corrigan
CEO who discussed shifting transportation demand toward automated systems and life-sciences expansion tied to FDA-regulated wearables.
- executiveEric Anderson
CFO who provided guidance details, interest income impact from repurchases, and free cash flow expectations.
